Granules India Limited

360 ONE AIF bought 2,86,535 shares of Granules India Limited for ₹25.00 Cr at ₹872.50 apiece in a block deal.

A pharmaceutical manufacturer engaged in producing Active Pharma Ingredients, Pharmaceutical Formulation Intermediates, and finished dosages for global markets. Granules India operates integrated manufacturing facilities across multiple locations in India, serving domestic and international customers in the pharmaceutical sector. The company specializes in complex chemical synthesis and formulation development for various therapeutic categories, including antibiotics, cardiovascular, and gastroenterology segments.

360 ONE AIF is the alternative investments arm of 360 ONE Asset Management, formerly IIFL Asset Management, part of the 360 ONE group. It manages alternative investment funds spanning listed equity, private equity and private credit strategies for sophisticated and institutional investors, led by chief investment officer Anup Maheshwari.